Format: Fireside chat Date: Wednesday, May 21, 2025 Time: 8:20 a.m. ET Webcast Link: Click Here About SELLAS Life Sciences Group, Inc. NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Dr. Angelos Stergiou, President and Chief Executive Officer of SELLAS, will participate in a fireside ...